Sponsor: Murdoch Childrens Research Institute
Collaborator: Friedreich Ataxia Research Alliance
Principal Investigator: Martin Delatycki, MBBS PhD, Murdoch Childrens Research Institute
ClinicalTrials.gov Identifier: NCT01339884
"The purpose of this study is to determine the effect of two doses of resveratrol taken for a 12 week period, on frataxin levels in individuals with Friedreich ataxia. This study will also measure the effect of resveratrol on markers of oxidative stress, clinical measures of ataxia, and cardiac parameters."
Thursday, April 21, 2011
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment